NDC 17856-0175-5 - ACETAMINOPHEN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17856-0175
- Requested NDC
- 17856-0175-5
- Package NDCs from labels
- 17856-0175-2, 17856-0175-1, 17856-0175-3, 17856-0175-5, 17856-0175-4, 17856-0175-6, 17856-0175-8, 17856-0175-7, 17856-0175-9
- Manufacturer
- ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS
- Effective date
- 2022-11-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ACETAMINOPHEN - ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | ATLANTIC BIOLOGICALS CORP. | UNIT DOSE SOLUTIONS | 2022-11-03 | HUMAN OTC DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17856-0175-3 | 2024-01-30 | C162847 | 48780-1 | 1030e365-54f6-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
| 17856-0175-6 | 2024-01-30 | C162847 | 48780-1 | 1030e365-54f6-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
| 17856-0175-9 | 2024-01-30 | C162847 | 48780-1 | 1030e365-54f6-111a-e063-dadaa90a10e2 | Acetaminophen Elxir Bubble Gum Flavor |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17856-0175-1 | ACETAMINOPHEN | 60 in 1 BOX, UNIT-DOSE | ELIXIR | 60 | 3 | |
| 17856-0175-2 | ACETAMINOPHEN | 2.5 mL in 1 SYRINGE | ELIXIR | 2.5 | 3 | |
| 17856-0175-3 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 3 | |
| 17856-0175-4 | ACETAMINOPHEN | 120 in 1 BOX, UNIT-DOSE | ELIXIR | 120 | 3 | |
| 17856-0175-5 | ACETAMINOPHEN | 2.5 mL in 1 SYRINGE | ELIXIR | 2.5 | 3 | |
| 17856-0175-6 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 3 | |
| 17856-0175-7 | ACETAMINOPHEN | 120 in 1 BOX, UNIT-DOSE | ELIXIR | 120 | 3 | |
| 17856-0175-8 | ACETAMINOPHEN | 2.5 mL in 1 SYRINGE | ELIXIR | 2.5 | 3 | |
| 17856-0175-9 | ACETAMINOPHEN | 5 in 1 SYRINGE | ELIXIR | 5 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17856-0175 | ACETAMINOPHEN ELIXIR [ATLANTIC BIOLOGICALS CORP.] | 3 | Legacy NDC, 9 package rows | 20221104_ed1583a6-5e10-462b-aba3-5f6137191ab5.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 17856-0175-7 | ML - Milliliter | 17856-0175 | deac2027-083f-4b34-b19c-076c3602e4d6 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetaminophen | ACETAMINOPHEN | PD-Rx Pharmaceuticals, Inc. | 3f96aeb1-a533-4d36-9a1f-62fc094b6754 | 2026-10-26 | Warnings | 362O9ITL9D |
| acetaminophen pain reliever fever reducer | ACETAMINOPHEN | Padagis Israel Pharmaceuticals Ltd | b43974c3-4db9-4201-beee-b22596a2b241 | 2026-10-26 | Warnings | 362O9ITL9D |
| Acetaminophen PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | FOODHOLD U.S.A., LLC | fdd7ce80-d6be-41b9-affd-d024cf306b50 | 2026-10-26 | Warnings | 362O9ITL9D |
| Bacteriostatic Water | WATER | Henry Schein, Inc. | a833502e-a622-4e81-8c58-cef6ccb6c4c9 | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| Headache Relief Extra Strength | ACETAMINOPHEN, ASPIRIN, CAFFEINE | CVS Pharmacy | 9e459853-5951-4ae7-88a6-85b502e9dd41 | 2026-10-26 | Warnings | 362O9ITL9D |
| MUCINEX FAST-MAX NIGHTTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 3a24b06c-00a6-c2ef-e063-6294a90a4d72 | 2026-10-25 | Warnings | 362O9ITL9D |
| Mucinex Nightshift Cold and Flu Maximum Strength | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, AND TRIPROLIDINE HYDROCHLORIDE | Reckitt Benckiser LLC | 316b5569-b66f-f30c-e063-6394a90ae147 | 2026-10-25 | Warnings | 362O9ITL9D |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 376e0289-28e9-e87f-e063-6294a90a3b04 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | f452a2c4-c869-7bf5-e053-2995a90ac1a0 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 10c3e31d-779d-8ff6-e063-6294a90acd39 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 86c14327-ffc7-806e-e053-2991aa0aaf92 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Mucinex Fast-Max Kickstart Severe Cold and Flu | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Reckitt Benckiser LLC | fda745ca-b486-47ca-e053-6394a90a87c3 | 2026-10-24 | Warnings | 362O9ITL9D |
| Excedrin Migraine | ACETAMINOPHEN, ASPIRIN, AND CAFFEINE | Select Consumer Group | 3caa4adf-abe3-67c3-e063-6294a90a87a4 | 2026-10-24 | Warnings | 362O9ITL9D |
| Excedrin Extra Strength Headache | ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE | Select Consumer Group | 3caa0a47-de83-90d2-e063-6394a90a3436 | 2026-10-24 | Warnings | 362O9ITL9D |
| MAX relief junior Grape | CHILDRENS ACETAMINOPHEN | Atlantic Biologicals Corp. | 5e38af7c-f5f3-6e5c-e063-6294a90a1772 | 2026-10-23 | Warnings | 362O9ITL9D |
| Clear Eyes Maximum Redness Relief | NAPHAZOLINE HYDROCHLORIDE AND GLYCERIN | Prestige Brands Holdings, Inc. | c3b0e344-68dd-4c35-bf46-744e612a5b15 | 2026-10-23 | Warnings | PDC6A3C0OX |
| Acetaminophen Extra Strength | ACETAMINOPHEN | CVS PHARMACY | 64a1ebe7-af28-4b09-96e8-28fa4dcc52bd | 2026-10-23 | Warnings | 362O9ITL9D |
| Tylenol Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | 7a60184f-91a9-4b85-b243-871deca63450 | 2026-10-22 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.